炎症因子と慢性鼻炎:総括的なレビュー
Stergios T Lialiaris1, Konstantinos Chaidas1, George Fyrmpas1
1Εar, Nose, and Throat Department, University Hospital of Alexandroupolis, School of Medicine, Democritus University of Thrace, Alexandroupolis, GRC.
Cureus
|February 19, 2026
まとめ
慢性鼻炎 (CRS) は,タイプ1,2,3の炎症を含む異なる免疫経路を伴う. これらのエンドタイプを理解することは,標的治療とCRSの効果的な管理の鍵です.
科学分野:
- 免疫学 免疫学とは
- 耳鼻喉科 (Otorhinolaryngology) は,耳鼻喉科 (Otorhinolaryngology) を専門とする医療機関である.
- 呼吸器医学とは
背景:
- 慢性鼻炎 (CRS) は,鼻経路と鼻に影響を与える一般的な炎症性疾患です.
- CRSは,異質な臨床的特徴と基礎的なメカニズムを示し,分類と治療を複雑にします.
- 鼻のポリプのないCRS (CRSsNP) と鼻のポリプを持つCRS (CRSwNP) の2つの主要な現象型が存在する.
研究 の 目的:
- CRSの異なる炎症経路と免疫パターンに関する証拠をレビューし,合成する.
- CRSエンドタイプの異質性とその臨床的影響を調査する.
- エンドタイプ主導の管理と生物学的治療法の可能性を評価する.
主な方法:
- PRISMAのガイドラインに従って総括的なレビューが行われました.
- ScopusとPubMedで体系的な文献検索が行われました.
- 1968年5月から2025年8月までの間に発表された64件の研究が含まれており,結果が質的に合成されました.
主要な成果:
- CRSの炎症には,異なるTヘルパー細胞 (Th1,Th2,Th17,Th22) とT調節細胞 (Treg) のパターンが含まれる.
- 1型炎症 (CRSsNPではしばしば) には,インターフェロン-ガンマ,IL-12,中性愛者の浸透が特徴です.
- 2型炎症 (CRSwNPではよく見られる) は,TSLP,IL-25,IL-33,Th2型サイトカイン,エオシノフィルを含み,粘液の産生と上皮の輸送に影響を及ぼします.
- 3型 (Th17) 炎症は,IL-17,IL-22と,宿主の微生物に対する防御と関連しています.
結論:
- CRSにおける炎症経路は多様で,重複し,疾患の現象型に影響を与える可能性があります.
- アスピリンによって悪化した呼吸器疾患やシスティックフィブロシスなどの併発症は,CRSのエンドタイプに影響を及ぼします.
- ドピルマブのような生物学的療法を含むエンドタイプ主導の管理は有望ですが,最適な患者層分化と治療選択のためにさらなる精細化が必要です.
関連する概念動画
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.9K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.9K
01:17Drugs Used in Lower Respiratory Disorders: Overview
1.2K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.2K
01:23Chronic Pharyngitis
12.8K
Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
12.8K
01:29Asthma-I: Introduction
3.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.6K
01:16Drugs Used in Upper Respiratory Disorders: Overview
719
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
719
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
3.9K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.9K